Outcomes of emergency department observation units for geriatric assessment: a systematic review and meta-analysis
Abstract
Introduction: Ageing populations present challenges for emergency departments (EDs), including rising ED attendances among older adults. Geriatric-centred ED observation units (Geri-EDOUs) provide a means of conducting comprehensive geriatric assessment (CGA) with a view to reduce or shorten acute hospitalisations. A systematic review and meta-analysis was conducted to summarise such interventions and evaluate their outcomes.
Methods: Seven databases were searched for relevant articles from their dates of inception to 16 December 2024. Articles describing the implementation of Geri-EDOUs with CGA for managing older patients aged 65 years and above were included. Study characteristics and clinical outcomes such as length of stay (LOS), hospital admission, discharge and readmission rates, ED reattendance rates and mortality were narratively synthesised. Meta-analysis was conducted where appropriate.
Results: Fourteen studies were included out of 5656 titles and abstracts screened. We identified three models of Geri-EDOUs, with varied patient profiles and diagnosis categories, unit staffing, patient selection and CGA components. We observed that Geri-EDOUs were associated with shorter LOS and lower hospital admission and readmission rates. Meta-analysis showed a pooled mean LOS of 2.82 days, a mortality rate of 9%, 50% of admissions saved and a 30-day ED readmission rate of 11%. No significant differences in mortality, readmission rates or admissions saved were found in…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.